These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 22999808)
21. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests. Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646 [TBL] [Abstract][Full Text] [Related]
22. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181 [TBL] [Abstract][Full Text] [Related]
23. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea. Diba C; King GG; Berend N; Salome CM Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC; Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies. Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371 [TBL] [Abstract][Full Text] [Related]
26. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD. Brophy C; Kastelik J; Gardiner E; Greenstone M Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097 [TBL] [Abstract][Full Text] [Related]
27. An evaluation of nebulized levalbuterol in stable COPD. Datta D; Vitale A; Lahiri B; ZuWallack R Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007 [TBL] [Abstract][Full Text] [Related]
28. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD. Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914 [TBL] [Abstract][Full Text] [Related]
29. Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease? Grootendorst DC; Gauw SA; Baan R; Kelly J; Murdoch RD; Sterk PJ; Rabe KF Pulm Pharmacol Ther; 2003; 16(2):115-20. PubMed ID: 12670781 [TBL] [Abstract][Full Text] [Related]
30. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study. Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766 [TBL] [Abstract][Full Text] [Related]
31. The role of domiciliary nebulizers in managing patients with severe COPD. Eiser N; Angus K; McHale S Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108 [TBL] [Abstract][Full Text] [Related]
32. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A; Szalai Z; Pullerits T; Radeczky E Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [TBL] [Abstract][Full Text] [Related]
33. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD? Eiser NM; Phillips C; Wooler PA Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505 [TBL] [Abstract][Full Text] [Related]
34. Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Pepin V; Brodeur J; Lacasse Y; Milot J; Leblanc P; Whittom F; Maltais F Thorax; 2007 Apr; 62(4):291-8. PubMed ID: 17099077 [TBL] [Abstract][Full Text] [Related]
35. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD. Norris V; Ambery C Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017 [TBL] [Abstract][Full Text] [Related]
36. Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD. Sukisaki T; Senjyu H; Oishi K; Rikitomi N; Ariyoshi K Physiother Theory Pract; 2008; 24(4):255-63. PubMed ID: 18574751 [TBL] [Abstract][Full Text] [Related]
37. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Eves ND; Petersen SR; Haykowsky MJ; Wong EY; Jones RL Am J Respir Crit Care Med; 2006 Oct; 174(7):763-71. PubMed ID: 16840742 [TBL] [Abstract][Full Text] [Related]
38. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators. Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993 [TBL] [Abstract][Full Text] [Related]
39. Effects of formoterol on exercise tolerance in severely disabled patients with COPD. Neder JA; Fuld JP; Overend T; Thirlwell J; Carter R; Stevenson R; Ward SA Respir Med; 2007 Oct; 101(10):2056-64. PubMed ID: 17658249 [TBL] [Abstract][Full Text] [Related]
40. Effects of acute salbutamol inhalation on quadriceps force and fatigability. Decorte N; Verges S; Flore P; Guinot M; Wuyam B Med Sci Sports Exerc; 2008 Jul; 40(7):1220-7. PubMed ID: 18580400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]